CIK 0001514946 · Non-accelerated filer<br>Smaller reporting company
AXIM BIOTECHNOLOGIES, INC.
Sign in to watch- Ticker
- AXIM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 274092986
- Phone
- (212) 751-0001
- Business address
- 6191 CORNERSTONE COURT, E, SUITE 114, SAN DIEGO, CA, 92121
- Former names
- AXIM INTERNATIONAL INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-10 | HUEMOELLER JOHN WALTER II Chief Executive Officer | Grant or award · Option | +3,000,000 | 5,000,000 | ||
| 2020-05-13 | Cunningham Robert L Director | Grant or award · Option | +500,000 | 500,000 | ||
| 2020-05-13 | Scott Timothy Richard Director | Grant or award · Option | +500,000 | 500,000 | ||
| 2020-03-19 | HUEMOELLER JOHN WALTER II Chief Executive Officer | Purchase | +6,000,000 | 6,000,000 | ||
| 2019-01-02 | HUEMOELLER JOHN WALTER II Chief Executive Officer | Grant or award · Option | +2,000,000 | 2,000,000 | ||
| 2018-03-21 | MALASEK ROBERT CFO | Grant or award | +50,000 | 50,000 | ||
| 2016-02-05 | Anastassov George President | Grant or award | +125,000 | 15,365,650 | ||
| 2015-12-18 | Changoer Lekhram Director | Grant or award | +25,000 | 25,000 | ||
| 2015-11-09 | Anastassov George President | Grant or award | +125,000 | 15,240,650 | ||
| 2015-07-02 | Anastassov George President | Grant or award | +500,000 | 15,240,650 | ||
| 2015-04-23 | Changoer Lekhram Director | Grant or award | +1,000,000 | 1,500,000 | ||
| 2015-04-23 | Anastassov George President | Grant or award | +1,000,000 | 1,500,000 | ||
| 2015-02-23 | Anastassov George President | Grant or award | +2,000 | 14,945,650 | ||
| 2014-03-21 | SAMUELS ROSEMARY PRESIDENT, CEO, CFO | Sale | −20,000,000 | $8,000.00 | $160.0B | 0 |
| 2014-03-21 | SAMUELS ROSEMARY PRESIDENT, CEO, CFO | Sale | −1,000,000 | $400.00 | $400.0M | 0 |
Page 2 of 2 · 35 trades